Invokana is a member of a family of diabetes drugs known as SGLT2 inhibitors, a newer class of Type 2 diabetes medication. Invokana works by stopping glucose from being reabsorbed into the blood. The medication is manufactured by Johnson & Johnson’s Janssen Pharmaceuticals, and was approved by the FDA in 2013. Since its introduction on the market, Invokana has been known to cause severe side effects in patients.
Invokana has been reported to cause serious side effects in users, including:
Bone Fracture Risk & Bone Density Decrease
The FDA recently strengthened their original warning that Invokana can increase a user’s risk of bone fracture. The Administration states that fractures can occur as early as 12 weeks after starting the drug. Other factors exist that can contribute to fracture risk prior to Invokana use, so patients should consult their doctor before beginning medication. In addition to an increased risk for bone fractures, Invokana has been associated with decreases in bone density in the hips and lower spines of patients.
Reports of kidney damage and failure occurring within Invokana users have been made since its first year on the market. If kidney damage occurs in a patient, waste products can build up in the blood causing a range of adverse effects, including fatigue, loss of appetite, cramps, and other conditions that affect the blood, bones, nerves, and skin. Kidney damage can ultimately lead to kidney failure and death.
Some patients using Invokana have suffered from diabetic comas caused by ketoacidosis, a condition in which keytones, or blood acids, are overproduced within the body. This occurs when the body loses the ability to produce enough insulin. Along with causing comas, Ketoacidosis can also be fatal.
Other Dangerous Drugs
Other SGLT2 inhibitors, including Invokamet, Farxiga, Xigduo XR, Jardiance, and Glyxambi, are also known to cause severe side effects within users.
Your Legal Options